Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Den nuværende pris på Moderna Inc på markedet er 374,87 kr. med en 24-timers handelsvolumen på 707,14M kr.. Aktivets markedsværdi er 149,66B kr., efter at have bevæget sig 4.75% i løbet af det seneste døgn.
Tokeniseret Moderna Inc handles til 373,7 kr. med en tokeniseret markedsværdi på 338,38K kr. og en 24-timers handelsvolumen på 16,31K kr.. Det tokeniserede aktiv har flyttet sig -2.15% i de seneste 24 timer.